Vertex Pharmaceuticals Incorporated (VRTX)
| Previous close | 481.26 |
| Open | 483.78 |
| Bid | 457.12 x 100 |
| Ask | 476.69 x 100 |
| Day's range | 475.90 - 483.78 |
| 52-week range | 341.85 - 510.64 |
| Volume | |
| Avg. volume | 1,145,848 |
| Market cap | 122.931B |
| Beta (5Y monthly) | 0.41 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -1.97 |
| Earnings date | 04 Nov 2024 - 08 Nov 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 513.97 |
Simply Wall St.Top High Growth Tech Stocks to Watch in September 2024
As global markets rebound from recent sell-offs, technology stocks have led the charge, significantly outpacing their value counterparts. With the S&P 500 Index recovering from its steepest decline since March 2023 and core inflation slightly higher than expected, investors are keenly watching high-growth tech stocks that can capitalize on these dynamic market conditions. In this context, a good stock to watch in the high-growth tech sector is one that demonstrates strong performance metrics...
ZacksVertex Pharmaceuticals (VRTX) Beats Stock Market Upswing: What Investors Need to Know
Vertex Pharmaceuticals (VRTX) closed at $489.43 in the latest trading session, marking a +0.84% move from the prior day.
ZacksIs Most-Watched Stock Vertex Pharmaceuticals Incorporated (VRTX) Worth Betting on Now?
Vertex (VRTX) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
